Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

Published:2015-02-17 Issue:5 Volume:112 Page:901-911
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Al-kaabi M M,Alshareeda A T,Jerjees D A,Muftah A A,Green A R,Alsubhi N H,Nolan C C,Chan S,Cornford E,Madhusudan S,Ellis I O,Rakha E A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2014576.pdf

Reference50 articles.

1. Agboola AO, Musa AA, Ayoade BA, Banjo AA, Anunobi CC, Deji-Agboola AM, Rakha EA, Nolan C, Ellis IO, Green AR (2014) Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women. Pathol Res Pract 210 (1): 10–17.

2. Ahn J, Urist M, Prives C (2004) The Chk2 protein kinase. DNA Rep (Amst) 3 (8-9): 1039–1047.

3. Aleskandarany MA, Green AR, Benhasouna AA, Barros FF, Neal K, Reis-Filho JS, Ellis IO, Rakha EA (2012) Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer. Breast Cancer Res 14 (1): R3.

4. Aleskandarany MA, Rakha EA, Ahmed MA, Powe DG, Ellis IO, Green AR (2011) Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer. Breast Cancer Res Treat 127 (2): 407–416.

5. Alshareeda AT, Negm OH, Albarakati N, Green AR, Nolan C, Sultana R, Madhusudan S, Benhasouna A, Tighe P, Ellis IO, Rakha EA (2013) Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Breast Cancer Res Treat 139 (2): 301–310.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin reverses EGFR-TKI therapeutic resistance by modulating crosstalk between circadian-related gene signature and immune infiltration patterns in patients with COVID-19 and lung adenocarcinoma;Computers in Biology and Medicine;2024-09

2. Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer;Acta Pharmaceutica Sinica B;2024-06

3. Combined Aurora Kinase A and CHK1 Inhibition Enhances Radiosensitivity of Triple-Negative Breast Cancer Through Induction of Apoptosis and Mitotic Catastrophe Associated With Excessive DNA Damage;International Journal of Radiation Oncology*Biology*Physics;2023-12

4. BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1;Cellular Signalling;2023-08

5. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas;Cancer Biomarkers;2023-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3